Apogee Therapeutics, Inc. APGE Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s total operating expenses?
- Apogee Therapeutics, Inc. (APGE) reported total operating expenses of $82.77M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Apogee Therapeutics, Inc.'s total operating expenses increased by 31.2% year-over-year, from $63.1M to $82.77M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s total operating expenses?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s total operating expenses has grown at a 75.2% compound annual growth rate (CAGR), from $93M to $285.6M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.